Evidence map›Paper›PMID 24167170›Full record

ArticlePediatrics2013

Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia.

Derek J Williams, Matthew Hall, Samir S Shah, Kavita Parikh, Amy Tyler, Mark I Neuman, Adam L Hersh, Thomas V Brogan, Anne J Blaschke, Carlos G Grijalva

Open access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in Pediatrics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. ImprovingAntibiotics (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

Derek J Williams1161 21st Ave South, CCC 5311 Medical Center North, Nashville, TN 37232. derek.williams@vanderbilt.edu.
Matthew Hall
Samir S Shah
Kavita Parikh
Amy Tyler
Mark I Neuman
Adam L Hersh
Thomas V Brogan
Anne J Blaschke
Carlos G Grijalva
Vanderbilt University · USChildren's Hospital Association · USGeorge Washington University · USHarvard University · USPrimary Children's Hospital · USUniversity of Cincinnati · USUniversity of Colorado Denver · USUniversity of Utah · USUniversity of Washington · US

Funding

Development and Validation of a Clinical Prediction Rule for Pediatric PneumoniaK23AI104779 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILLIAMS, DEREK J. · 2013 to 2016
$688k
NIAID NIH HHS K23 AI104779
6 · The paper itself

Abstract

backgroundThe 2011 Pediatric Infectious Diseases Society/Infectious Diseases Society of America community-acquired pneumonia (CAP) guideline recommends narrow-spectrum antimicrobial therapy for most children hospitalized with CAP. However, few studies have assessed the effectiveness of this strategy.

methodsUsing data from 43 children's hospitals, we conducted a retrospective cohort study to compare outcomes and resource utilization among children hospitalized with CAP between 2005 and 2011 receiving either parenteral ampicillin/penicillin (narrow spectrum) or ceftriaxone/cefotaxime (broad spectrum). Children with complex chronic conditions, interhospital transfers, recent hospitalization, or the occurrence of any of the following during the first 2 calendar days of hospitalization were excluded: pleural drainage procedure, admission to intensive care, mechanical ventilation, death, or hospital discharge.

resultsOverall, 13,954 children received broad-spectrum therapy (89.7%) and 1610 received narrow-spectrum therapy (10.3%). The median length of stay was 3 days (interquartile range 3-4) in the broad- and narrow-spectrum therapy groups (adjusted difference 0.12 days, 95% confidence interval [CI]: -0.02 to 0.26). One hundred fifty-six children (1.1%) receiving broad-spectrum therapy and 13 children (0.8%) receiving narrow-spectrum therapy were admitted to intensive care (adjusted odds ratio 0.85, 95% CI: 0.27 to 2.73). Readmission occurred for 321 children (2.3%) receiving broad-spectrum therapy and 39 children (2.4%) receiving narrow-spectrum therapy (adjusted odds ratio 0.85, 95% CI: 0.45 to 1.63). Median costs for the hospitalization were $3992 and $4375 (adjusted difference -$14.4, 95% CI: -177.1 to 148.3).

conclusionsClinical outcomes and costs for children hospitalized with CAP are not different when treatment is with narrow- compared with broad-spectrum therapy.

Indexed as

HospitalizationAmpicillinAnti-Bacterial AgentsCefotaximeCeftriaxoneChild, PreschoolCohort StudiesDrug Therapy, CombinationFemaleHumansInfantMalePenicillinsPneumoniaRetrospective StudiesAmpicillinAnti-Bacterial AgentsCefotaximeCeftriaxonePenicillinsantibiotic useeffectivenesspediatricspneumonia

Identifiers

PMID24167170
PMCPMC4530302
OpenAlexW2083414152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.